OPGx-CNGB1

N/A

Report date: 2024/07/01 17:39:55

Base Information

Drug NameOPGx-CNGB1
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionCyclic nucleotide-gated cation channel beta-1 gene transference
TargetsCyclic nucleotide-gated cation channel beta-1
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida Research Foundation IncUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesOpus Genetics Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A